Cargando…
NKG2D ligands link oncogenic RAS to innate immunity
RAS is constitutively active in multiple types of tumor cells. We have recently demonstrated that H-RASV12 enhances the translation of ligands for the activating immune receptor NKG2D, hence rendering cells more susceptible to natural killer (NK) cell-mediated lysis. This effect depends on MAPK and...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583909/ https://www.ncbi.nlm.nih.gov/pubmed/23482418 http://dx.doi.org/10.4161/onci.22244 |
_version_ | 1782475504185507840 |
---|---|
author | Ho, Samantha S.W. Gasser, Stephan |
author_facet | Ho, Samantha S.W. Gasser, Stephan |
author_sort | Ho, Samantha S.W. |
collection | PubMed |
description | RAS is constitutively active in multiple types of tumor cells. We have recently demonstrated that H-RASV12 enhances the translation of ligands for the activating immune receptor NKG2D, hence rendering cells more susceptible to natural killer (NK) cell-mediated lysis. This effect depends on MAPK and PI3K signaling, but not on the DNA damage response. |
format | Online Article Text |
id | pubmed-3583909 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Landes Bioscience |
record_format | MEDLINE/PubMed |
spelling | pubmed-35839092013-03-11 NKG2D ligands link oncogenic RAS to innate immunity Ho, Samantha S.W. Gasser, Stephan Oncoimmunology Author's View RAS is constitutively active in multiple types of tumor cells. We have recently demonstrated that H-RASV12 enhances the translation of ligands for the activating immune receptor NKG2D, hence rendering cells more susceptible to natural killer (NK) cell-mediated lysis. This effect depends on MAPK and PI3K signaling, but not on the DNA damage response. Landes Bioscience 2013-01-01 /pmc/articles/PMC3583909/ /pubmed/23482418 http://dx.doi.org/10.4161/onci.22244 Text en Copyright © 2013 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited. |
spellingShingle | Author's View Ho, Samantha S.W. Gasser, Stephan NKG2D ligands link oncogenic RAS to innate immunity |
title | NKG2D ligands link oncogenic RAS to innate immunity |
title_full | NKG2D ligands link oncogenic RAS to innate immunity |
title_fullStr | NKG2D ligands link oncogenic RAS to innate immunity |
title_full_unstemmed | NKG2D ligands link oncogenic RAS to innate immunity |
title_short | NKG2D ligands link oncogenic RAS to innate immunity |
title_sort | nkg2d ligands link oncogenic ras to innate immunity |
topic | Author's View |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583909/ https://www.ncbi.nlm.nih.gov/pubmed/23482418 http://dx.doi.org/10.4161/onci.22244 |
work_keys_str_mv | AT hosamanthasw nkg2dligandslinkoncogenicrastoinnateimmunity AT gasserstephan nkg2dligandslinkoncogenicrastoinnateimmunity |